External quality assurance of malaria nucleic acid testing for clinical trials and eradication surveillance.

External quality assurance of malaria nucleic acid testing for clinical trials and eradication surveillance.

Nucleic acid testing (NAT) for malaria parasites is an increasingly recommended diagnostic endpoint in clinical trials of vaccine and drug candidates and is also important in surveillance of malaria control and elimination efforts. A variety of reported NAT assays have been described, yet no formal...

Full description

Bibliographic Details
Main Authors: Sean C Murphy, Cornelus C Hermsen, Alexander D Douglas, Nick J Edwards, Ines Petersen, Gary A Fahle, Matthew Adams, Andrea A Berry, Zachary P Billman, Sarah C Gilbert, Matthew B Laurens, Odile Leroy, Kristen E Lyke, Christopher V Plowe, Annette M Seilie, Kathleen A Strauss, Karina Teelen, Adrian V S Hill, Robert W Sauerwein
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4023973?pdf=render

Internet

http://europepmc.org/articles/PMC4023973?pdf=render

Similar Items